Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Pharma, Inc. | 362,389 | reported | 18 May 2026 | tx 23+240,304−272,806 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 May 2026 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 22,781 | 66.13 USD | 10b5-1 |
| 18 May 2026 | SALE | BridgeBio Pharma, Inc. | 10,456 | 64.82 USD | 10b5-1 |
| 18 May 2026 | SALE | BridgeBio Pharma, Inc. | 3,195 | 65.95 USD | 10b5-1 |
| 18 Mar 2026 | GRANT_AWARD | BridgeBio Pharma, Inc. | 59,041 | 0.00 USD | |
| 16 Feb 2026 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 18,819 | 75.25 USD | |
| 17 Feb 2026 | SALE | BridgeBio Pharma, Inc. | 200 | 75.38 USD | |
| 17 Feb 2026 | SALE | BridgeBio Pharma, Inc. | 13,400 | 74.71 USD | |
| 12 Dec 2025 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 13,826 | 75.15 USD | |
| 16 Nov 2025 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 21,317 | 66.39 USD | |
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 6,956 | 66.84 USD | |
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 9,978 | 66.19 USD | |
| 21 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 42,237 | 49.48 USD | |
| 16 Aug 2025 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 21,317 | 51.32 USD | |
| 18 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 15,380 | 50.14 USD | |
| 18 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 1,973 | 50.94 USD | |
| 16 May 2025 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 21,317 | 33.84 USD | |
| 19 Mar 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 109,100 | 0.00 USD | |
| 16 Feb 2025 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 13,782 | 34.90 USD | |
| 10 Dec 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 50,000 | 0.00 USD | |
| 16 Nov 2024 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 17,936 | 23.72 USD | |
| 16 Aug 2024 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 17,936 | 24.40 USD | |
| 06 Aug 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 19,003 | 0.00 USD | |
| 06 Aug 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 3,160 | 0.00 USD | deriv |